Global Metoclopramide Market 2024-2030
  • CHOOSE LICENCE TYPE
Consulting Services
    How will you benefit from our consulting services ?

Global Metoclopramide Market 2024-2030

Last Updated:  Apr 25, 2025 | Study Period: 2024-2030

METOCLOPRAMIDE MARKET

 

INTRODUCTION TOMETOCLOPRAMIDE MARKET

A drug called methoclopramide is used to treat esophageal and stomach issues. It is frequently used to treat and prevent nausea and vomiting, to assist those who have gastroesophageal reflux disease in having their stomachs empty more quickly, and to treat and prevent nausea and vomiting in healthy individuals.

 

Moreover, migraine headaches are treated with it. The anti-sickness drug metoclopramide is used to treat nausea and vomiting.

 

It might not be appropriate for some people, such as those who have Parkinson's disease, epilepsy, high blood pressure, cirrhosis, kidney disease, congestive heart failure, or preexisting gastrointestinal issues (such as haemorrhage, obstruction, or perforation); pheochromocytoma; or a history of intolerance to metoclopramide. 

 

METOCLOPRAMIDE MARKET SIZE AND FORECAST

 

Infographic: Metoclopramide Market, Metoclopramide Market Size, Metoclopramide Market Trends, Metoclopramide Market Forecast, Metoclopramide Market Risks, Metoclopramide Market Report, Metoclopramide Market Share

 

The Global Metoclopramide Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

 

METOCLOPRAMIDE MARKETNEW PRODUCT LAUNCH

Metoclopramide Injection Is Introduced by Teva The generic version of Reglan injection made by Baxter, called Metoclopramide Injection, has been introduced by Teva.

 

Metoclopramide is an antidopaminergic indicated for relief of symptoms associated with acute and recurrent diabetic gastric stasis, prophylaxis of vomiting associated with emetogenic cancer chemotherapy, prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable, to facilitate small bowel intubation in adults and paediatric patients in whom the tube does not pass the pylorus with conventional manoeuvres, and to stimulate gastric emptying and intestinal transit of barium in cases where delayed emptying interferes with radiological examination of the stomach and/or small intestine.

 

Metoclopramide works by stimulating motility of the upper gastrointestinal tract without stimulating gastric, biliary, or pancreatic secretions. Along with accelerating gastric emptying and intestinal transit, it also makes the pyloric sphincter and duodenal bulb more relaxed.

 

It also increases the tone and amplitude of gastric contractions and the peristalsis of the duodenum and jejunum. Additionally, it raises the lower esophageal sphincter's resting tone.

 

Metoclopramide Injection is available in a 5mg/mL strength in 2mL single-use vials Through many acquisitions that integrated and boosted its expertise in novel and generic medications, as well as new therapeutic areas and markets, Teva saw considerable global growth. Teva is one of the top 15 pharmaceutical firms in the world today and a pioneer in the development of speciality and generic drugs.

 

METOCLOPRAMIDE MARKETCOMPANY PROFILE

 

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS OFMETOCLOPRAMIDE MARKET

  1. How many Metoclopramide are manufactured per annum globally? Who are the sub-component suppliers in different regions?
  2. Cost breakup of a Global Metoclopramide and key vendor selection criteria
  3. Where is Metoclopramide manufactured? What is the average margin per unit?
  4. Market share of Global Metoclopramide market manufacturers and their upcoming products
  5. Cost advantage for OEMs who manufacture Global Metoclopramide in-house
  6. key predictions for next 5 years in Global Metoclopramide market
  7. Average B-2-B Metoclopramide market price in all segments
  8. Latest trends in Metoclopramide market, by every market segment
  9. The market size (both volume and value) of the Metoclopramide market in 2024-2030 and every year in between?
  10. Production breakup of Metoclopramide market, by suppliers and their OEM relationship

 

Sl noTopic
1Market Segmentation
2Scope of the report
3Abbreviations
4Research Methodology
5Executive Summary
6Introduction
7Insights from Industry stakeholders
8Cost breakdown of Product by sub-components and average profit margin
9Disruptive innovation in the Industry
10Technology trends in the Industry
11Consumer trends in the industry
12Recent Production Milestones
13Component Manufacturing in US, EU and China
14COVID-19 impact on overall market
15COVID-19 impact on Production of components
16COVID-19 impact on Point of sale
17Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
18Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
19Market Segmentation, Dynamics and Forecast by Application, 2024-2030
20Market Segmentation, Dynamics and Forecast by End use, 2024-2030
21Product installation rate by OEM, 2023
22Incline/Decline in Average B-2-B selling price in past 5 years
23Competition from substitute products
24Gross margin and average profitability of suppliers
25New product development in past 12 months
26M&A in past 12 months
27Growth strategy of leading players
28Market share of vendors, 2023
29Company Profiles
30Unmet needs and opportunity for new suppliers
31Conclusion
32Appendix